Neutrophil survival at 24 hours was significantly decreased after ivacaftor therapy, suggesting that CFTR potentiation reverses the prosurvival phenotype in CF neutrophils (figure 2A–C, p=0.014). Here, CFTR is linked to cystic fibrosis.